Literature DB >> 3276782

Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.

J R Zucali1, H E Broxmeyer, M A Gross, C A Dinarello.   

Abstract

The influences of TNF alpha and TNF beta were evaluated for their stimulatory and inhibitory effects on in vitro colony formation by human bone marrow granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells. Both TNF alpha and TNF beta induced fibroblasts to produce stimulators of CFU-GM, BFU-E, and CFU-GEMM in a dose-dependent fashion. Similar results were seen when equivalent concentrations of TNF alpha and TNF beta were used. Prior incubation of the TNF alpha and TNF beta with their respective antibodies inactivated the ability of the TNF preparations to induce the release of granulocyte-macrophage, erythroid, and multipotential colony-stimulating activity from fibroblasts. In addition, incubation of the TNF-induced fibroblast supernatant with antibody before colony assay resulted in enhanced colony formation, suggesting that the TNF carried over into the colony assay suppressed colony formation. Additional proof of this suppression by TNF was evident when TNF was added directly to the CFU-GM, BFU-E, and CFU-GEMM colony assays. IL-1 does not appear to function as an intermediary in growth factor production by fibroblasts stimulated with TNF because antibody to IL-1 displayed no effect. Furthermore, assay of TNF-induced fibroblast supernatant was negative for IL-1. These results suggest that TNF alpha and TNF beta exert both a positive and negative influence on in vitro hemopoietic colony formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 2.  Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.

Authors:  G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 3.  Tumour necrosis factor: a cytokine with multiple biological activities.

Authors:  G Semenzato
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

4.  Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation.

Authors:  S E Jacobsen; F W Ruscetti; C M Dubois; J R Keller
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

5.  Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.

Authors:  N Coté; D R Trout; A M Hayes
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

6.  Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level.

Authors:  V I Rebel; S Hartnett; G R Hill; S B Lazo-Kallanian; J L Ferrara; C A Sieff
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

7.  Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells.

Authors:  H E Broxmeyer; B Sherry; L Lu; S Cooper; C Carow; S D Wolpe; A Cerami
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

8.  Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation.

Authors:  K Mizuno; S Sone; E Orino; A Nii; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02

9.  Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.

Authors:  S Fujii; Y Liu; H Neda; Y Itoh; Y Koshita; M Takahashi; N Watanabe; Y Kohgo; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1994-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.